Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
23/02/2026
In January, Switzerland's M3 money supply increased by 5.1% year-on-year.
Latest
4 m ago
After the weight loss drug of Novo Nordisk did not perform as well as Lilly's drug in the trial, Lilly's stock price rose 2.1% in pre-market trading.
4 m ago
Novo Nordisk (NVO.N) stated that in clinical trials, the effectiveness of the company's Cagrisema did not meet the efficacy standard of Eli Lilly's Tirzepatide.
9 m ago
Novartis and Nordisk indicated that in clinical trials, the efficacy of KAGLEQI peptide is not as good as LiLai's teripetide.
9 m ago
Este Lauder CEO: "We will always be involved in merger and acquisition discussions."
10 m ago
The stock prices of Nu and Nord fell by 10% after the release of the results of the REDEFINE 4 trial.
See all latest